A multistakeholder study explores how law enforcement presence in EDs affects survivors of violence and outlines ...
Patients with moderate to severe allergic rhinitis (AR) often experience years of uncontrolled symptoms, worsened quality of ...
The results of the phase 3 MajesTEC-9 trial showcase teclistamab's efficacy for patients with relapsed/refractory multiple ...
Early phase 1 data suggest that in vivo, off-the-shelf CAR T therapy may be feasible in multiple myeloma, offering the ...
The bipartisan funding bill prevents a government shutdown, ensuring uninterrupted operations for key agencies, including HHS ...
Anlotinib combined with chemotherapy showed a 30.8% ORR and 82.7% DCR in advanced STS patients, indicating promising efficacy ...
Infant protection against respiratory syncytial virus (RSV) by maternal RSV vaccination or receipt of RSV monoclonal antibody ...
IPF-associated cough affects up to 80% of patients with IPF, substantially impairing their quality of life; consequently, ...
Overall, MajesTEC-3 signals a meaningful step forward for combination bispecific therapies in multiple myeloma, while ...
Michael Wang, MD, highlights standout translational studies from ASH 2025 that advance understanding of prognosis and drug ...
Severe alopecia areata may be driven by broader immune activation than previously recognized, according to new research ...
Michael Wang, MD, highlights ASH 2025 data showing how continual innovation across targeted agents, cellular and immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results